Cargando…
The Evaluation of Xiaozeng Qianggu Tablets for Treating Postmenopausal Osteoporosis via up-Regulated Autophagy
OBJECTIVE: Postmenopausal osteoporosis (PMOP) is a common age-associated disease in the life course. Clinically, Xiaozeng Qianggu Tablets (XQT) have a potent therapeutic effect on the PMOP. However, the bioactive components and the mechanism of XQT underlying the PMOP treatment were unclear and it s...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526660/ https://www.ncbi.nlm.nih.gov/pubmed/36193128 http://dx.doi.org/10.1155/2022/3960834 |
_version_ | 1784800928190169088 |
---|---|
author | Wu, Mingquan Lai, Huabing Deng, Qing Peng, Xi Shen, Jingshou Zhou, Xu Peng, Wei Zhu, Liyang Tu, He Li, Xia |
author_facet | Wu, Mingquan Lai, Huabing Deng, Qing Peng, Xi Shen, Jingshou Zhou, Xu Peng, Wei Zhu, Liyang Tu, He Li, Xia |
author_sort | Wu, Mingquan |
collection | PubMed |
description | OBJECTIVE: Postmenopausal osteoporosis (PMOP) is a common age-associated disease in the life course. Clinically, Xiaozeng Qianggu Tablets (XQT) have a potent therapeutic effect on the PMOP. However, the bioactive components and the mechanism of XQT underlying the PMOP treatment were unclear and it should be explored to discover the scientific connotation in traditional medical practice. METHODS: The components in XQT were identified by UPLC-Q-TOF/MS. The animal model of PMOP was established by surgical ovariectomy in the female Sprague-Dawley rats. After treatment of XQT, the therapeutic effect was assessed by the determination of bone metabolism biomarkers in serum and histopathological examination. The effect of XQT on the autophagy and bone micro-situation were tested using western blot, RT-qPCR, and transmission electron microscope. RESULTS: There were 27 compounds identified in XQT, including catalpol, monotropein, verbascoside, cryptochlorogenic acid, 5,7-dihydroxychromone 7-rutinoside, biorobin, and so on. The bone metabolism markers (alkaline phosphatase, bone alkaline phosphatase, procollagen type I intact N-terminal propeptide, cross-linked carboxy-terminal telopeptide of type I collagen, and tartrate-resistant acid phosphatase) were significantly increased in the PMOP rats and reversed by XQT administration. Moreover, the width of bone trabeculae and the ratio of the area of calcium deposition to bone trabeculae were also improved after treating the middle dose of XQT. Meanwhile, the bone micro-structure was improved by XQT. The mRNA and protein expression of unc-51 like kinase 1, beclin-1, and microtubule-associated protein 1B-light chain 3 in PMOP rats were down-regulated and up-regulated by XQT administration. CONCLUSIONS: The compounds in XQT, including catalpol, monotropein, verbascoside cryptochlorogenic acid, and so on, were valuable for further pharmacy evaluation. The pathological changes and bone micro-structure were improved by XQT, and the down-regulated autophagy level was also restored, which suggested a potent effect of XQT on treating PMOP, corresponding to its clinic use. |
format | Online Article Text |
id | pubmed-9526660 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-95266602022-10-02 The Evaluation of Xiaozeng Qianggu Tablets for Treating Postmenopausal Osteoporosis via up-Regulated Autophagy Wu, Mingquan Lai, Huabing Deng, Qing Peng, Xi Shen, Jingshou Zhou, Xu Peng, Wei Zhu, Liyang Tu, He Li, Xia Evid Based Complement Alternat Med Research Article OBJECTIVE: Postmenopausal osteoporosis (PMOP) is a common age-associated disease in the life course. Clinically, Xiaozeng Qianggu Tablets (XQT) have a potent therapeutic effect on the PMOP. However, the bioactive components and the mechanism of XQT underlying the PMOP treatment were unclear and it should be explored to discover the scientific connotation in traditional medical practice. METHODS: The components in XQT were identified by UPLC-Q-TOF/MS. The animal model of PMOP was established by surgical ovariectomy in the female Sprague-Dawley rats. After treatment of XQT, the therapeutic effect was assessed by the determination of bone metabolism biomarkers in serum and histopathological examination. The effect of XQT on the autophagy and bone micro-situation were tested using western blot, RT-qPCR, and transmission electron microscope. RESULTS: There were 27 compounds identified in XQT, including catalpol, monotropein, verbascoside, cryptochlorogenic acid, 5,7-dihydroxychromone 7-rutinoside, biorobin, and so on. The bone metabolism markers (alkaline phosphatase, bone alkaline phosphatase, procollagen type I intact N-terminal propeptide, cross-linked carboxy-terminal telopeptide of type I collagen, and tartrate-resistant acid phosphatase) were significantly increased in the PMOP rats and reversed by XQT administration. Moreover, the width of bone trabeculae and the ratio of the area of calcium deposition to bone trabeculae were also improved after treating the middle dose of XQT. Meanwhile, the bone micro-structure was improved by XQT. The mRNA and protein expression of unc-51 like kinase 1, beclin-1, and microtubule-associated protein 1B-light chain 3 in PMOP rats were down-regulated and up-regulated by XQT administration. CONCLUSIONS: The compounds in XQT, including catalpol, monotropein, verbascoside cryptochlorogenic acid, and so on, were valuable for further pharmacy evaluation. The pathological changes and bone micro-structure were improved by XQT, and the down-regulated autophagy level was also restored, which suggested a potent effect of XQT on treating PMOP, corresponding to its clinic use. Hindawi 2022-09-19 /pmc/articles/PMC9526660/ /pubmed/36193128 http://dx.doi.org/10.1155/2022/3960834 Text en Copyright © 2022 Mingquan Wu et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Wu, Mingquan Lai, Huabing Deng, Qing Peng, Xi Shen, Jingshou Zhou, Xu Peng, Wei Zhu, Liyang Tu, He Li, Xia The Evaluation of Xiaozeng Qianggu Tablets for Treating Postmenopausal Osteoporosis via up-Regulated Autophagy |
title | The Evaluation of Xiaozeng Qianggu Tablets for Treating Postmenopausal Osteoporosis via up-Regulated Autophagy |
title_full | The Evaluation of Xiaozeng Qianggu Tablets for Treating Postmenopausal Osteoporosis via up-Regulated Autophagy |
title_fullStr | The Evaluation of Xiaozeng Qianggu Tablets for Treating Postmenopausal Osteoporosis via up-Regulated Autophagy |
title_full_unstemmed | The Evaluation of Xiaozeng Qianggu Tablets for Treating Postmenopausal Osteoporosis via up-Regulated Autophagy |
title_short | The Evaluation of Xiaozeng Qianggu Tablets for Treating Postmenopausal Osteoporosis via up-Regulated Autophagy |
title_sort | evaluation of xiaozeng qianggu tablets for treating postmenopausal osteoporosis via up-regulated autophagy |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526660/ https://www.ncbi.nlm.nih.gov/pubmed/36193128 http://dx.doi.org/10.1155/2022/3960834 |
work_keys_str_mv | AT wumingquan theevaluationofxiaozengqianggutabletsfortreatingpostmenopausalosteoporosisviaupregulatedautophagy AT laihuabing theevaluationofxiaozengqianggutabletsfortreatingpostmenopausalosteoporosisviaupregulatedautophagy AT dengqing theevaluationofxiaozengqianggutabletsfortreatingpostmenopausalosteoporosisviaupregulatedautophagy AT pengxi theevaluationofxiaozengqianggutabletsfortreatingpostmenopausalosteoporosisviaupregulatedautophagy AT shenjingshou theevaluationofxiaozengqianggutabletsfortreatingpostmenopausalosteoporosisviaupregulatedautophagy AT zhouxu theevaluationofxiaozengqianggutabletsfortreatingpostmenopausalosteoporosisviaupregulatedautophagy AT pengwei theevaluationofxiaozengqianggutabletsfortreatingpostmenopausalosteoporosisviaupregulatedautophagy AT zhuliyang theevaluationofxiaozengqianggutabletsfortreatingpostmenopausalosteoporosisviaupregulatedautophagy AT tuhe theevaluationofxiaozengqianggutabletsfortreatingpostmenopausalosteoporosisviaupregulatedautophagy AT lixia theevaluationofxiaozengqianggutabletsfortreatingpostmenopausalosteoporosisviaupregulatedautophagy AT wumingquan evaluationofxiaozengqianggutabletsfortreatingpostmenopausalosteoporosisviaupregulatedautophagy AT laihuabing evaluationofxiaozengqianggutabletsfortreatingpostmenopausalosteoporosisviaupregulatedautophagy AT dengqing evaluationofxiaozengqianggutabletsfortreatingpostmenopausalosteoporosisviaupregulatedautophagy AT pengxi evaluationofxiaozengqianggutabletsfortreatingpostmenopausalosteoporosisviaupregulatedautophagy AT shenjingshou evaluationofxiaozengqianggutabletsfortreatingpostmenopausalosteoporosisviaupregulatedautophagy AT zhouxu evaluationofxiaozengqianggutabletsfortreatingpostmenopausalosteoporosisviaupregulatedautophagy AT pengwei evaluationofxiaozengqianggutabletsfortreatingpostmenopausalosteoporosisviaupregulatedautophagy AT zhuliyang evaluationofxiaozengqianggutabletsfortreatingpostmenopausalosteoporosisviaupregulatedautophagy AT tuhe evaluationofxiaozengqianggutabletsfortreatingpostmenopausalosteoporosisviaupregulatedautophagy AT lixia evaluationofxiaozengqianggutabletsfortreatingpostmenopausalosteoporosisviaupregulatedautophagy |